The Comprehensive Biomaterial Bank Marburg (CBBMR) has been operated as a core facility by the Department of Human Medicine at the Philipps University of Marburg since 2014. As a structured biosample collection, CBBMR contributes directly to the improvement of translational research by offering the systematic collection, recording and provision of biosamples under standardised and quality-assured conditions. The linking of each individual sample with the corresponding clinical data creates added value in terms of information, which benefits both research into the causes of diseases and studies on the development of more effective treatment approaches tailored to individual patients.
The Marburg Biobank focuses on providing tumour tissue for research at the Anneliese Pohl Cancer Centre, but research groups in psychiatry and inflammation research as well as study teams in reproductive medicine and lung research also work closely with the Marburg Biobank. The cooperation between CBBMR and the Institute of Pathology enables access to a collection of old samples of formalin-fixed, paraffin-embedded (FFPE) tissue blocks stored there, with samples dating back to the century before last.
In addition to the provision of biosamples, CBBMR offers advice on the design of project biobanks, centralised sample and data management in collaborative projects, quality-assured storage of old sample collections and the design and production of tissue micro-arrays (TMA).
As part of research consortia, CBBMR develops new pre-analytical applications and storage methods. An organoid biobank for lung and pancreas is currently being established in the cell culture area.
CBBMR is a member of the BMBF-funded German Centre for Lung Research (DZL), the DFG-funded research groups FOR 2107 "Neurobiology of affective disorders" and KliFo 325 "Microenvironment of pancreatic ductal adenocarcinoma (PDAC)" as well as the FOR "Functional clustering of T cell and other immune cell sub-phenotypes across plasticity and individualities of immune-mediated diseases", funded by the Else-Kröner-Fresenius-Foundation.
Accreditation and certification
Certified according to DIN EN ISO 9001:2015
